Katrin Dubischar

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 223 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl et al. · The Lancet Infectious Diseases · 2020 · 106 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers

Nicole Bézay, Andrea Ayad, Katrin Dubischar et al. · Vaccine · 2016 · 85 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial

Christopher Adlbrecht, Raphael Wurm, Pieter Depuydt et al. · Critical Care · 2020 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial

Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak et al. · The Lancet Infectious Diseases · 2022 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17